A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older

Trial Profile

A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Atropine/chlorphenamine/pseudoephedrine (Primary) ; Atropine; Pseudoephedrine/chlorphenamine
  • Indications Seasonal allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors MAGNA Pharmaceuticals
  • Most Recent Events

    • 29 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 31 Mar 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 21 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top